欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/2124/004
药品名称
Rivaroxaban Orion
活性成分
RIVAROXABAN 20.0 mg
剂型
Film-coated tablet
上市许可持有人
Orion Corporation, Finland
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Denmark (DK)
Norway (NO)
Finland (FI)
Poland (PL)
Rivaroxaban Orion
Latvia (LV)
Lithuania (LT)
Rivaroxaban Orion 20 mg plėvele dengtos
Estonia (EE)
Hungary (HU)
Czechia (CZ)
Rivaroxaban Orion
许可日期
2023/02/23
最近更新日期
2024/01/11
药物ATC编码
B01AF01 rivaroxaban
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
PubAR
|
PAR
Date of last change:2024/09/06
PubAR Summary
|
PAR Summary
Date of last change:2024/09/06
Final SPC
|
Rivaroxaban Orion
Date of last change:2024/09/06
Final PL
|
Rivaroxaban Orion_2
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase